Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Delayed Quote USD

Clover Health Investments, Corp. (CLOV)

Compare
3.5900
-0.1100
(-2.97%)
At close: March 28 at 4:00:00 PM EDT
3.5700
-0.02
(-0.56%)
After hours: March 28 at 7:55:10 PM EDT
Loading Chart for CLOV
  • Previous Close 3.7000
  • Open 3.6700
  • Bid 2.6400 x 100
  • Ask 3.6200 x 4300
  • Day's Range 3.4950 - 3.7000
  • 52 Week Range 0.6060 - 4.8700
  • Volume 5,052,508
  • Avg. Volume 6,091,908
  • Market Cap (intraday) 1.834B
  • Beta (5Y Monthly) 2.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0900
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.75

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through one segment: Insurance. It also offers Clover Assistant, a cloud-based software platform that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights about the patients they treat. The company was founded in 2014 and is headquartered in Wilmington, Delaware.

www.cloverhealth.com/en/

570

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CLOV
13.97%
S&P 500 (^GSPC)
5.11%

1-Year Return

CLOV
352.14%
S&P 500 (^GSPC)
6.22%

3-Year Return

CLOV
0.55%
S&P 500 (^GSPC)
21.97%

5-Year Return

CLOV
64.35%
S&P 500 (^GSPC)
119.59%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    1.83B

  • Enterprise Value

    1.50B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.28

  • Price/Book (mrq)

    5.38

  • Enterprise Value/Revenue

    1.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.14%

  • Return on Assets (ttm)

    -4.99%

  • Return on Equity (ttm)

    -14.75%

  • Revenue (ttm)

    1.37B

  • Net Income Avi to Common (ttm)

    -46.27M

  • Diluted EPS (ttm)

    -0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    221.56M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    200.78M

Research Analysis: CLOV

View More

Company Insights: CLOV

Research Reports: CLOV

View More

People Also Watch